Page 4 - Nyse Path News Today

Swiss National Bank acquired a new stake in shares of UiPath Inc. (NYSE:PATH – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,281,100 shares of the healthcare company’s stock, valued at approximately $21,228,000. Swiss National Bank owned about 0.23% of […]

2023.10 platform release includes powerful new capabilities with Specialised AI and Generative AI, new developer productivity tools, and UiPath Automa...

UiPath Inc. (NYSE:PATH – Get Free Report) Director Rich Wong sold 100,000 shares of the business’s stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $18.07, for a total transaction of $1,807,000.00. Following the transaction, the director now directly owns 756,599 shares of the company’s stock, valued […]

UiPath Inc. (NYSE:PATH – Get Free Report) Director Rich Wong sold 100,000 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $18.07, for a total value of $1,807,000.00. Following the sale, the director now directly owns 756,599 shares of the company’s stock, valued […]

UiPath Inc. (NYSE:PATH – Get Free Report) has received an average recommendation of “Hold” from the fourteen brokerages that are presently covering the company, MarketBeat reports. Eight equities research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year price objective among brokerages […]

Citizens Financial Group Inc. RI bought a new position in UiPath Inc. (NYSE:PATH – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 21,680 shares of the healthcare company’s stock, valued at approximately $359,000. Other large investors have also […]

Oppenheimer & Co. Inc. increased its position in UiPath Inc. (NYSE:PATH – Free Report) by 14.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 202,469 shares of the healthcare company’s stock after buying an additional 25,147 shares during the period. Oppenheimer […]

COMPANY NEWS:  UiPath (NYSE: PATH), a leading enterprise automation software company, today announced UiPath Clipboard AI has been selected as on...

Shares of UiPath Inc. (NYSE:PATH – Get Free Report) have been assigned an average recommendation of “Hold” from the fifteen research firms that are presently covering the firm, MarketBeat Ratings reports. Nine equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average […]

Needham & Company LLC reiterated their buy rating on shares of UiPath (NYSE:PATH – Free Report) in a research report report published on Wednesday, Benzinga reports. They currently have a $20.00 price target on the healthcare company’s stock. Several other equities analysts have also commented on the stock. Barclays upped their price objective on shares […]